Tag: Tezepelumab

AstraZeneca, Amgen asthma drug tezepelumab secures FDA breakthrough designation

pharmanewsdaily- September 9, 2018

UK biopharma company AstraZeneca and Amgen have secured breakthrough therapy designation from the US Food and Drug Administration (FDA) for their asthma drug tezepelumab. The ... Read More